The Endovascular Plus GENe Therapy Versus Only EndoVascular Therapy for Severe Limb ischaemiA Trial

NCT06473740 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

386

Enrollment

OTHER

Sponsor class

Conditions

Severe Lower Limb Ischemia

Interventions

DRUG: Deoxyribonucleic acid supercoiled plasmid pCMV-VEGF165 (Neovasculgen)

Sponsor

Amur State Medical Academy